Inflammatory myopathies and overlap syndromes: Update on histological and serological profile.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Baillière's Best Practice & Research : Clinical Rheumatology

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.berh.2016.02.005PMID 27107515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Clinical Features of Myositis-Associated Autoantibodies: a Review

  2017cited by this paper
• Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy.

  2015cited by this paper
• Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management

  2015cited by this paper
• Inflammatory muscle diseases.

  2015cited by this paper
• Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome

  2015cited by this paper
• Necrotizing Myopathies: An Update

  2015cited by this paper
• SLE myopathy: a clinicopathological study

  2015cited by this paper
• Myositis in primary Sjögren's syndrome: data from a multicentre cohort.

  2015cited by this paper
• Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies

  2014cited by this paper
• Rheumatoid myositis, myth or reality? A clinical, imaging and histological study.

  2014cited by this paper
• Myositis autoantibodies and clinical phenotypes

  2014cited by this paper
• Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

  2014cited by this paper
• Autoantibodies to RuvBL1 and RuvBL2: A Novel Systemic Sclerosis–Related Antibody Associated With Diffuse Cutaneous and Skeletal Muscle Involvement

  2014cited by this paper
• Clinical and Serologic Correlates of Anti‐PM/Scl Antibodies in Systemic Sclerosis: A Multicenter Study of 763 Patients

  2014cited by this paper
• Statin‐associated autoimmune myopathy and anti‐HMGCR autoantibodies

  2013cited by this paper
• Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

  2013cited by this paper
• A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.

  2013cited by this paper
• Non-inflammatory myopathies

  2013cited by this paper
• Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria.

  2013cited by this paper
• Anti–Melanoma Differentiation–Associated Protein 5–Associated Dermatomyositis: Expanding the Clinical Spectrum

  2013cited by this paper
• The 15% Rule in Scleroderma: The Frequency of Severe Organ Complications in Systemic Sclerosis. A Systematic Review

  2013cited by this paper
• Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia?

  2012cited by this paper
• Anti-PM-Scl antibody in patients with systemic sclerosis.

  2012cited by this paper
• Aldolase predicts subsequent myopathy occurrence in systemic sclerosis

  2012cited by this paper
• Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms

  2012cited by this paper
• Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.

  2012cited by this paper
• Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis.

  2012cited by this paper
• Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.

  2012cited by this paper
• Systemic lupus erythematosusmyositis overlap syndrome: report of 6 cases

  2011cited by this paper
• MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies

  2010cited by this paper
• Fatigue in Sjogren's syndrome: relationship with fibromyalgia, clinical and biologic features.

  2010cited by this paper
• Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008.

  2010cited by this paper
• Fatigue in Sjögren's syndrome: relationship with fibromyalgia, clinical and biological features

  2010cited by this paper
• Immunohistochemical study of skeletal muscle in rheumatoid myositis.

  2009cited by this paper
• [Primary Sjögren syndrome and inclusion body myositis].

  2009cited by this paper
• Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota.

  2008cited by this paper
• A descriptive and prognostic study of systemic sclerosis-associated myopathies

  2008cited by this paper
• Systemic Sclerosis‐Associated Myopathy

  2007cited by this paper
• Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

  2006cited by this paper
• Anti-Mi-2 antibodies

  2005cited by this paper
• Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies: Analysis of 100 French Canadian Patients

  2005cited by this paper
• Clinical and laboratory features of scleroderma patients developing skeletal myopathy

  2005cited by this paper
• [Association of systemic lupus erythematosus and dermatopolymyositis].

  2005cited by this paper
• 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

  2004cited by this paper
• SLE/myositis overlap: are the manifestations of SLE different in overlap disease?

  2002cited by this paper
• Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain.

  2002cited by this paper
• Primary Sjögren's syndrome associated with inclusion body myositis.

  2002cited by this paper
• Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle.

  2001cited by this paper
• Autoantibodies and overlap syndromes in autoimmune rheumatic disease

  2001cited by this paper
• Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

  2001cited by this paper
• Increased cellularity and expression of adhesion molecules in muscle biopsy specimens from patients with rheumatoid arthritis with clinical suspicion of vasculitis, but negative routine histology

  2000cited by this paper
• Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases.

  1997cited by this paper
• Autoantibodies in systemic sclerosis.

  1996cited by this paper
• Inclusion body myositis and myopathies

  1995cited by this paper
• Myositis in primary Sjögren's syndrome. Report of 3 cases.

  1994cited by this paper
• Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters.

  1994cited by this paper
• Muscular involvement in systemic rheumatoid vasculitis.

  1992cited by this paper
• Polymyositis, dermatomyositis and inclusion-body myositis.

  1991cited by this paper
• Muscle involvement in the scleroderma syndromes.

  1990cited by this paper
• Neuropathy and myopathy in primary Sjögren's syndrome: neurophysiological, immunological and muscle biopsy results

  1990cited by this paper
• Inclusion body myositis and Sjogren's syndrome.

  1985cited by this paper
• Rheumatoid myositis. Clinical and histologic features and possible pathogenesis.

  1984cited by this paper
• Inclusion body myositis associated with Sjögren's syndrome.

  1982cited by this paper
• The Investigation of Inflammatory Myopathy

  1981cited by this paper
• Muscle involvement in systemic lupus erythematosus.

  1981cited by this paper
• Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.

  1978cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper
• Skeletal muscle involvement in progressive systemic sclerosis (scleroderma).

  1968cited by this paper
• Arteritis of striated muscle in rheumatoid arthritis.

  1951cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet. Polymyositis and Dermatomyositis

  year unknowncited by this paper

• Associations between TNF gene promoter variants (rs361525, rs1800629, rs1799964, rs1799724) and the clinical course of idiopathic inflammatory myopathies

  2025cites this paper
• The Etiopathogenesis and Genetic Factors in Idiopathic Inflammatory Myopathies: A Review Article

  2023cites this paper
• Joint and muscle inflammatory disease: A scoping review of the published evidence.

  2023cites this paper
• Rhabdomyolysis-associated acute kidney injury in a teenager: Answers

  2022cites this paper
• Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort

  2021cites this paper
• Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients

  2021cites this paper
• Peripheral nervous system manifestations of rheumatological diseases.

  2021cites this paper
• Skeletal muscle disease in rheumatoid arthritis: the center of cardiometabolic comorbidities?

  2020cites this paper
• Inclusion body myositis in the rheumatology clinic

  2020cites this paper
• The Role of Autoantibodies in Idiopathic Inflammatory Myopathies

  2019cites this paper
• Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient

  2019cites this paper
• Comment on: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al

  2019cites this paper
• Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient.

  2019cites this paper
• An international survey of developing classification criteria for juvenile dermatomyositis-scleroderma overlap.

  2019cites this paper
• Yellow Fever Vaccine as a Possible Trigger of Inflammatory Myopathy: A Case Report.

  2019cites this paper
• Distinguishing Disease Activity and Damage in Myositis

  2019cites this paper
• Response to: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al

  2019cites this paper
• Dermatomyositis: clinicopathological correlations.

  2018cites this paper
• Comparative immunoprofiling of polymyositis and dermatomyositis muscles.

  2018cites this paper
• The clinico-serological spectrum of overlap myositis

  2018cites this paper
• Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy

  2018cites this paper
• Bench to bedside review of myositis autoantibodies

  2018cites this paper
• IgG4-Related Sclerosing Cholangitis Involving the Intrahepatic Bile Ducts Diagnosed with Liver Biopsy

  2018cites this paper
• University of Southern Denmark IgG4-Related Sclerosing Cholangitis Involving the Intrahepatic Bile Ducts Diagnosed with Liver Biopsy Thinesen,

  2018cites this paper
• Polimiosite no diagnóstico diferencial de dor torácica aguda

  2017cites this paper
• Idiopathic inflammatory myopathies overlapping with systemic diseases

  2017cites this paper
• The Clinical and Pathological Spectrum of Idiopathic Inflammatory Myopathies : Implications for pathogenesis, classification and diagnosis

  2016cites this paper